PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company engaged in the discovery & development of RNA-based therapeutics for the treatment of severe genetic disorders.

$7.11  +0.53 (8.06%)
As of 12/07/2021 11:47:15 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  09/18/2014
Outstanding shares:  50,204,810
Average volume:  267,067
Market cap:   $331,351,746
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    N71542109
ISIN:        NL0010872495
Sedol:      BQRX1W2
Valuation   (See tab for details)
PE ratio:   -10.73
PB ratio:   3.64
PS ratio:   262.67
Return on equity:   -44.02%
Net income %:   -5,077.76%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy